Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP‐1 Receptor Agonists: A Systematic Review and Meta‐Analysis
ABSTRACT Aims Glaucoma, a leading cause of irreversible blindness, is particularly prevalent among individuals with Type 2 Diabetes Mellitus (T2DM), a known risk factor for the disease. This systematic review and meta‐analysis aimed to evaluate the incidence of glaucoma in T2DM patients treated with...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Endocrinology, Diabetes & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1002/edm2.70059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|